News

Learn more about how C3i takes part in the development of new cell and gene therapies.

Nov 13, 2017

C3i’s Biomarker and Diagnostic unit now offers TCR-beta sequencing services

The Center for Commercialization of Cancer Immunotherapy (C3i) is proud to announce the availability of T cell receptor-beta sequencing services in its Biomarker and Diagnostic unit.

Learn more

Sep 30, 2017

C3i participates to the challenge Cycle for a Cure!

The 6th edition of the Bike Challenge for Cellular Therapy Research at the Maisonneuve-Rosemont Hospital will give you the opportunity to support scientific work that promotes healing.

Learn more